Award
Delivery Order #SPE2DR26F1CN3
Delivery Order for RINVOQ ER Tablets Under AmerisourceBergen's Pharmaceutical IDV
Buyer
Defense Logistics Agency
Award Amount
$31,888.42
Ceiling
$31,888.42
Awarded
February 27, 2026
Period of Performance
Feb 27, 2026 – Mar 02, 2026
Identifier
SPE2DR26F1CN3
NAICS
424210
This award represents a definitive delivery order contract issued under an existing indefinite delivery vehicle (IDV) held by AmerisourceBergen Drug Corporation, a leading healthcare solutions provider specializing in pharmaceutical distribution. The contract procures RINVOQ ER 45 MG tablets, an essential pharmaceutical product, demonstrating the agency's ongoing commitment to maintaining a reliable supply of critical medications. The work covers the delivery of these specified pharmaceutical items to the designated location in Conshohocken, PA, within a short, specific timeframe. Awarded through established contractual arrangements under the parent IDV, this delivery order reflects a streamlined procurement process leveraging AmerisourceBergen's proven capabilities in pharmaceutical logistics. The short-term fulfillment period ensures timely access to vital medications, reinforcing the agency's public health objectives. This contract continues the effective partnership between the agency and AmerisourceBergen established under a long-term IDV contract for pharmaceutical services, further supporting the healthcare supply chain's stability and responsiveness.
Description
4570985163!RINVOQ ER 45 MG TABLET UU 28S